CN108450962A - 一种用于女士保健的固体饮料及其制备方法 - Google Patents
一种用于女士保健的固体饮料及其制备方法 Download PDFInfo
- Publication number
- CN108450962A CN108450962A CN201810162283.8A CN201810162283A CN108450962A CN 108450962 A CN108450962 A CN 108450962A CN 201810162283 A CN201810162283 A CN 201810162283A CN 108450962 A CN108450962 A CN 108450962A
- Authority
- CN
- China
- Prior art keywords
- extract
- selenium
- solid beverage
- amino acid
- plant extracts
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000036541 health Effects 0.000 title claims abstract description 29
- 235000013361 beverage Nutrition 0.000 title claims abstract description 24
- 239000007787 solid Substances 0.000 title claims abstract description 24
- 238000002360 preparation method Methods 0.000 title claims description 7
- 239000000284 extract Substances 0.000 claims abstract description 62
- 239000011669 selenium Substances 0.000 claims abstract description 51
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims abstract description 51
- 229910052711 selenium Inorganic materials 0.000 claims abstract description 49
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 claims abstract description 48
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims abstract description 37
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims abstract description 36
- 229960003080 taurine Drugs 0.000 claims abstract description 25
- 240000006698 Spigelia anthelmia Species 0.000 claims abstract description 24
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims abstract description 22
- 239000011575 calcium Substances 0.000 claims abstract description 22
- 229910052791 calcium Inorganic materials 0.000 claims abstract description 22
- 244000046146 Pueraria lobata Species 0.000 claims abstract description 21
- 235000010575 Pueraria lobata Nutrition 0.000 claims abstract description 21
- 239000000843 powder Substances 0.000 claims abstract description 21
- -1 compound amino acid Chemical class 0.000 claims abstract description 19
- 229940088594 vitamin Drugs 0.000 claims abstract description 19
- 239000011782 vitamin Substances 0.000 claims abstract description 19
- 239000004471 Glycine Substances 0.000 claims abstract description 18
- 229930003427 Vitamin E Natural products 0.000 claims abstract description 18
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims abstract description 18
- 239000000419 plant extract Substances 0.000 claims abstract description 18
- 235000019165 vitamin E Nutrition 0.000 claims abstract description 18
- 239000011709 vitamin E Substances 0.000 claims abstract description 18
- 229940046009 vitamin E Drugs 0.000 claims abstract description 18
- 235000002532 grape seed extract Nutrition 0.000 claims abstract description 16
- 229940087603 grape seed extract Drugs 0.000 claims abstract description 16
- 239000001717 vitis vinifera seed extract Substances 0.000 claims abstract description 16
- 108010038807 Oligopeptides Proteins 0.000 claims abstract description 14
- 102000015636 Oligopeptides Human genes 0.000 claims abstract description 14
- CANRESZKMUPMAE-UHFFFAOYSA-L Zinc lactate Chemical compound [Zn+2].CC(O)C([O-])=O.CC(O)C([O-])=O CANRESZKMUPMAE-UHFFFAOYSA-L 0.000 claims abstract description 14
- 239000011576 zinc lactate Substances 0.000 claims abstract description 14
- 229940050168 zinc lactate Drugs 0.000 claims abstract description 14
- 235000000193 zinc lactate Nutrition 0.000 claims abstract description 14
- 241000251468 Actinopterygii Species 0.000 claims abstract description 13
- 239000011573 trace mineral Substances 0.000 claims abstract description 13
- 235000013619 trace mineral Nutrition 0.000 claims abstract description 13
- 239000005862 Whey Substances 0.000 claims abstract description 12
- 102000007544 Whey Proteins Human genes 0.000 claims abstract description 12
- 108010046377 Whey Proteins Proteins 0.000 claims abstract description 12
- 239000000203 mixture Substances 0.000 claims abstract description 10
- 239000000463 material Substances 0.000 claims abstract description 7
- 239000002994 raw material Substances 0.000 claims description 15
- 239000004615 ingredient Substances 0.000 claims description 14
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 claims description 13
- 235000013734 beta-carotene Nutrition 0.000 claims description 13
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 claims description 13
- 239000011648 beta-carotene Substances 0.000 claims description 13
- 229960002747 betacarotene Drugs 0.000 claims description 13
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 claims description 13
- 210000000582 semen Anatomy 0.000 claims description 8
- 244000077995 Coix lacryma jobi Species 0.000 claims description 6
- 239000002245 particle Substances 0.000 claims description 6
- 238000005469 granulation Methods 0.000 claims description 5
- 230000003179 granulation Effects 0.000 claims description 5
- 238000001035 drying Methods 0.000 claims description 3
- 238000007689 inspection Methods 0.000 claims description 3
- 238000004806 packaging method and process Methods 0.000 claims description 3
- 238000012856 packing Methods 0.000 claims description 3
- 230000001954 sterilising effect Effects 0.000 claims description 3
- 238000003860 storage Methods 0.000 claims description 3
- 230000003712 anti-aging effect Effects 0.000 abstract description 16
- 239000000262 estrogen Substances 0.000 abstract description 12
- 229940011871 estrogen Drugs 0.000 abstract description 11
- 230000036039 immunity Effects 0.000 abstract description 10
- 230000007170 pathology Effects 0.000 abstract description 4
- 150000001875 compounds Chemical class 0.000 abstract description 2
- 230000000694 effects Effects 0.000 description 39
- 230000006870 function Effects 0.000 description 21
- 235000001014 amino acid Nutrition 0.000 description 16
- 235000011034 Rubus glaucus Nutrition 0.000 description 15
- 244000235659 Rubus idaeus Species 0.000 description 15
- 235000009122 Rubus idaeus Nutrition 0.000 description 15
- 230000003078 antioxidant effect Effects 0.000 description 14
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 13
- 239000011701 zinc Substances 0.000 description 13
- 229910052725 zinc Inorganic materials 0.000 description 13
- 102000011632 Caseins Human genes 0.000 description 12
- 108010076119 Caseins Proteins 0.000 description 12
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 12
- 239000003963 antioxidant agent Substances 0.000 description 12
- 235000006708 antioxidants Nutrition 0.000 description 12
- 230000004060 metabolic process Effects 0.000 description 12
- 239000005018 casein Substances 0.000 description 11
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 11
- 235000021240 caseins Nutrition 0.000 description 11
- 235000016709 nutrition Nutrition 0.000 description 11
- 241001248610 Ophiocordyceps sinensis Species 0.000 description 10
- 230000015572 biosynthetic process Effects 0.000 description 10
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 description 10
- 235000008696 isoflavones Nutrition 0.000 description 10
- 230000002265 prevention Effects 0.000 description 10
- 230000009102 absorption Effects 0.000 description 9
- 238000010521 absorption reaction Methods 0.000 description 9
- 150000003254 radicals Chemical class 0.000 description 9
- 239000000126 substance Substances 0.000 description 9
- 241000219780 Pueraria Species 0.000 description 8
- 150000001413 amino acids Chemical class 0.000 description 8
- 210000004027 cell Anatomy 0.000 description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 8
- GOMNOOKGLZYEJT-UHFFFAOYSA-N isoflavone Chemical compound C=1OC2=CC=CC=C2C(=O)C=1C1=CC=CC=C1 GOMNOOKGLZYEJT-UHFFFAOYSA-N 0.000 description 8
- 239000000047 product Substances 0.000 description 8
- 235000018102 proteins Nutrition 0.000 description 8
- 102000004169 proteins and genes Human genes 0.000 description 8
- 108090000623 proteins and genes Proteins 0.000 description 8
- 239000013589 supplement Substances 0.000 description 8
- 238000003786 synthesis reaction Methods 0.000 description 8
- KQLDDLUWUFBQHP-UHFFFAOYSA-N Cordycepin Natural products C1=NC=2C(N)=NC=NC=2N1C1OCC(CO)C1O KQLDDLUWUFBQHP-UHFFFAOYSA-N 0.000 description 7
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 7
- 208000001132 Osteoporosis Diseases 0.000 description 7
- 108010001441 Phosphopeptides Proteins 0.000 description 7
- 230000001093 anti-cancer Effects 0.000 description 7
- 230000003796 beauty Effects 0.000 description 7
- OFEZSBMBBKLLBJ-BAJZRUMYSA-N cordycepin Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)C[C@H]1O OFEZSBMBBKLLBJ-BAJZRUMYSA-N 0.000 description 7
- OFEZSBMBBKLLBJ-UHFFFAOYSA-N cordycepine Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(CO)CC1O OFEZSBMBBKLLBJ-UHFFFAOYSA-N 0.000 description 7
- 239000003814 drug Substances 0.000 description 7
- 208000024891 symptom Diseases 0.000 description 7
- 102000004190 Enzymes Human genes 0.000 description 6
- 108090000790 Enzymes Proteins 0.000 description 6
- 208000021663 Female sexual arousal disease Diseases 0.000 description 6
- 208000006262 Psychological Sexual Dysfunctions Diseases 0.000 description 6
- 230000032683 aging Effects 0.000 description 6
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 6
- 230000007423 decrease Effects 0.000 description 6
- 150000004676 glycans Chemical class 0.000 description 6
- 229910052742 iron Inorganic materials 0.000 description 6
- 229920001282 polysaccharide Polymers 0.000 description 6
- 239000005017 polysaccharide Substances 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 102000008186 Collagen Human genes 0.000 description 5
- 108010035532 Collagen Proteins 0.000 description 5
- 229920001436 collagen Polymers 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 230000036737 immune function Effects 0.000 description 5
- 230000001976 improved effect Effects 0.000 description 5
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 5
- 230000035764 nutrition Effects 0.000 description 5
- 210000001519 tissue Anatomy 0.000 description 5
- 238000011282 treatment Methods 0.000 description 5
- 241001264174 Cordyceps militaris Species 0.000 description 4
- 101000904173 Homo sapiens Progonadoliberin-1 Proteins 0.000 description 4
- 206010020772 Hypertension Diseases 0.000 description 4
- 206010027304 Menopausal symptoms Diseases 0.000 description 4
- 206010028980 Neoplasm Diseases 0.000 description 4
- 102100024028 Progonadoliberin-1 Human genes 0.000 description 4
- 101000996723 Sus scrofa Gonadotropin-releasing hormone receptor Proteins 0.000 description 4
- 230000009471 action Effects 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 238000013329 compounding Methods 0.000 description 4
- 230000006378 damage Effects 0.000 description 4
- 238000011161 development Methods 0.000 description 4
- 230000018109 developmental process Effects 0.000 description 4
- 235000013399 edible fruits Nutrition 0.000 description 4
- 230000002708 enhancing effect Effects 0.000 description 4
- 239000000686 essence Substances 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- XLXSAKCOAKORKW-UHFFFAOYSA-N gonadorelin Chemical compound C1CCC(C(=O)NCC(N)=O)N1C(=O)C(CCCN=C(N)N)NC(=O)C(CC(C)C)NC(=O)CNC(=O)C(NC(=O)C(CO)NC(=O)C(CC=1C2=CC=CC=C2NC=1)NC(=O)C(CC=1NC=NC=1)NC(=O)C1NC(=O)CC1)CC1=CC=C(O)C=C1 XLXSAKCOAKORKW-UHFFFAOYSA-N 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 235000015097 nutrients Nutrition 0.000 description 4
- 108090000765 processed proteins & peptides Proteins 0.000 description 4
- 230000001502 supplementing effect Effects 0.000 description 4
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 3
- 108090000209 Carbonic anhydrases Proteins 0.000 description 3
- 102000003846 Carbonic anhydrases Human genes 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- 206010062767 Hypophysitis Diseases 0.000 description 3
- 244000241872 Lycium chinense Species 0.000 description 3
- 235000015468 Lycium chinense Nutrition 0.000 description 3
- 208000037093 Menstruation Disturbances Diseases 0.000 description 3
- 206010027339 Menstruation irregular Diseases 0.000 description 3
- 208000008589 Obesity Diseases 0.000 description 3
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 3
- 241000219095 Vitis Species 0.000 description 3
- 235000009754 Vitis X bourquina Nutrition 0.000 description 3
- 235000012333 Vitis X labruscana Nutrition 0.000 description 3
- 235000014787 Vitis vinifera Nutrition 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 230000004913 activation Effects 0.000 description 3
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 3
- 230000003064 anti-oxidating effect Effects 0.000 description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
- 230000036772 blood pressure Effects 0.000 description 3
- 201000011510 cancer Diseases 0.000 description 3
- YKPUWZUDDOIDPM-SOFGYWHQSA-N capsaicin Chemical compound COC1=CC(CNC(=O)CCCC\C=C\C(C)C)=CC=C1O YKPUWZUDDOIDPM-SOFGYWHQSA-N 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 230000002526 effect on cardiovascular system Effects 0.000 description 3
- 230000002124 endocrine Effects 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 230000001076 estrogenic effect Effects 0.000 description 3
- 229940032591 grape seed extract 50 mg Drugs 0.000 description 3
- 230000012010 growth Effects 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 150000002632 lipids Chemical class 0.000 description 3
- 235000010755 mineral Nutrition 0.000 description 3
- 239000011707 mineral Substances 0.000 description 3
- 210000004165 myocardium Anatomy 0.000 description 3
- 235000020824 obesity Nutrition 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- 230000000144 pharmacologic effect Effects 0.000 description 3
- 230000035790 physiological processes and functions Effects 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 210000001525 retina Anatomy 0.000 description 3
- 230000001568 sexual effect Effects 0.000 description 3
- 235000014347 soups Nutrition 0.000 description 3
- 230000002195 synergetic effect Effects 0.000 description 3
- 210000001541 thymus gland Anatomy 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 235000019155 vitamin A Nutrition 0.000 description 3
- 239000011719 vitamin A Substances 0.000 description 3
- 229940045997 vitamin a Drugs 0.000 description 3
- 150000003722 vitamin derivatives Chemical class 0.000 description 3
- 206010000234 Abortion spontaneous Diseases 0.000 description 2
- 201000004384 Alopecia Diseases 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 241000283690 Bos taurus Species 0.000 description 2
- 241000190633 Cordyceps Species 0.000 description 2
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 2
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 2
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 2
- 102000004163 DNA-directed RNA polymerases Human genes 0.000 description 2
- 108090000626 DNA-directed RNA polymerases Proteins 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 241000282326 Felis catus Species 0.000 description 2
- 208000031226 Hyperlipidaemia Diseases 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 102000004877 Insulin Human genes 0.000 description 2
- 108090001061 Insulin Proteins 0.000 description 2
- 206010022998 Irritability Diseases 0.000 description 2
- 102000004407 Lactalbumin Human genes 0.000 description 2
- 108090000942 Lactalbumin Proteins 0.000 description 2
- 229930195725 Mannitol Natural products 0.000 description 2
- 208000007101 Muscle Cramp Diseases 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- 208000002193 Pain Diseases 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 description 2
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 2
- 206010047791 Vulvovaginal dryness Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- DNVZXPMGIDEPFF-UHFFFAOYSA-N [Se].[Zn].[Ca] Chemical compound [Se].[Zn].[Ca] DNVZXPMGIDEPFF-UHFFFAOYSA-N 0.000 description 2
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000000259 anti-tumor effect Effects 0.000 description 2
- 239000006286 aqueous extract Substances 0.000 description 2
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 2
- 230000031018 biological processes and functions Effects 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 229960002504 capsaicin Drugs 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 230000004663 cell proliferation Effects 0.000 description 2
- 230000007969 cellular immunity Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 230000001276 controlling effect Effects 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 208000035475 disorder Diseases 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 230000002255 enzymatic effect Effects 0.000 description 2
- 102000015694 estrogen receptors Human genes 0.000 description 2
- 108010038795 estrogen receptors Proteins 0.000 description 2
- 230000001815 facial effect Effects 0.000 description 2
- 229930003944 flavone Natural products 0.000 description 2
- 150000002212 flavone derivatives Chemical class 0.000 description 2
- 235000011949 flavones Nutrition 0.000 description 2
- 210000004907 gland Anatomy 0.000 description 2
- 229940094952 green tea extract Drugs 0.000 description 2
- 235000020688 green tea extract Nutrition 0.000 description 2
- 230000005802 health problem Effects 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- 235000012907 honey Nutrition 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 230000001900 immune effect Effects 0.000 description 2
- 201000001881 impotence Diseases 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 208000021267 infertility disease Diseases 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- 229940125396 insulin Drugs 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 150000002515 isoflavone derivatives Chemical class 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 230000033001 locomotion Effects 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 235000010355 mannitol Nutrition 0.000 description 2
- 239000000594 mannitol Substances 0.000 description 2
- 230000009245 menopause Effects 0.000 description 2
- 230000027939 micturition Effects 0.000 description 2
- 208000015994 miscarriage Diseases 0.000 description 2
- 230000000116 mitigating effect Effects 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 208000010125 myocardial infarction Diseases 0.000 description 2
- 230000003204 osmotic effect Effects 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 239000003075 phytoestrogen Substances 0.000 description 2
- 230000008092 positive effect Effects 0.000 description 2
- 230000035755 proliferation Effects 0.000 description 2
- 230000001850 reproductive effect Effects 0.000 description 2
- 238000012827 research and development Methods 0.000 description 2
- 230000014860 sensory perception of taste Effects 0.000 description 2
- 208000000995 spontaneous abortion Diseases 0.000 description 2
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 210000005239 tubule Anatomy 0.000 description 2
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 2
- 230000029663 wound healing Effects 0.000 description 2
- 230000037303 wrinkles Effects 0.000 description 2
- BHQCQFFYRZLCQQ-UHFFFAOYSA-N (3alpha,5alpha,7alpha,12alpha)-3,7,12-trihydroxy-cholan-24-oic acid Natural products OC1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 BHQCQFFYRZLCQQ-UHFFFAOYSA-N 0.000 description 1
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 208000010470 Ageusia Diseases 0.000 description 1
- 206010001497 Agitation Diseases 0.000 description 1
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 1
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 1
- 102000014303 Amyloid beta-Protein Precursor Human genes 0.000 description 1
- 108010079054 Amyloid beta-Protein Precursor Proteins 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 206010003694 Atrophy Diseases 0.000 description 1
- 206010004053 Bacterial toxaemia Diseases 0.000 description 1
- 206010004542 Bezoar Diseases 0.000 description 1
- 208000019838 Blood disease Diseases 0.000 description 1
- 239000002126 C01EB10 - Adenosine Substances 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 208000002177 Cataract Diseases 0.000 description 1
- 206010008111 Cerebral haemorrhage Diseases 0.000 description 1
- 239000004380 Cholic acid Substances 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 206010010144 Completed suicide Diseases 0.000 description 1
- 208000032170 Congenital Abnormalities Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 108050006400 Cyclin Proteins 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- 108020004414 DNA Proteins 0.000 description 1
- 240000001879 Digitalis lutea Species 0.000 description 1
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 1
- 206010013883 Dwarfism Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 208000004483 Dyspareunia Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 208000017701 Endocrine disease Diseases 0.000 description 1
- 208000008967 Enuresis Diseases 0.000 description 1
- DNXHEGUUPJUMQT-CBZIJGRNSA-N Estrone Chemical compound OC1=CC=C2[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CCC2=C1 DNXHEGUUPJUMQT-CBZIJGRNSA-N 0.000 description 1
- PNNNRSAQSRJVSB-SLPGGIOYSA-N Fucose Natural products C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C=O PNNNRSAQSRJVSB-SLPGGIOYSA-N 0.000 description 1
- 208000010412 Glaucoma Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- MVORZMQFXBLMHM-QWRGUYRKSA-N Gly-His-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)CN)CC1=CN=CN1 MVORZMQFXBLMHM-QWRGUYRKSA-N 0.000 description 1
- 206010053759 Growth retardation Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 101710154606 Hemagglutinin Proteins 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 208000004044 Hypesthesia Diseases 0.000 description 1
- 206010020989 Hypogeusia Diseases 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- 238000012404 In vitro experiment Methods 0.000 description 1
- 201000001429 Intracranial Thrombosis Diseases 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- 208000019926 Keshan disease Diseases 0.000 description 1
- SHZGCJCMOBCMKK-DHVFOXMCSA-N L-fucopyranose Chemical compound C[C@@H]1OC(O)[C@@H](O)[C@H](O)[C@@H]1O SHZGCJCMOBCMKK-DHVFOXMCSA-N 0.000 description 1
- 108090001030 Lipoproteins Proteins 0.000 description 1
- 102000004895 Lipoproteins Human genes 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 102000002151 Microfilament Proteins Human genes 0.000 description 1
- 108010040897 Microfilament Proteins Proteins 0.000 description 1
- 206010059013 Nocturnal emission Diseases 0.000 description 1
- 206010067572 Oestrogenic effect Diseases 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 101710093908 Outer capsid protein VP4 Proteins 0.000 description 1
- 101710135467 Outer capsid protein sigma-1 Proteins 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 208000006399 Premature Obstetric Labor Diseases 0.000 description 1
- 206010036600 Premature labour Diseases 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 102100036691 Proliferating cell nuclear antigen Human genes 0.000 description 1
- 101710176177 Protein A56 Proteins 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 208000034189 Sclerosis Diseases 0.000 description 1
- 206010039921 Selenium deficiency Diseases 0.000 description 1
- 206010041497 Spermatorrhoea Diseases 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 239000005864 Sulphur Substances 0.000 description 1
- 102000019197 Superoxide Dismutase Human genes 0.000 description 1
- 108010012715 Superoxide dismutase Proteins 0.000 description 1
- 208000024799 Thyroid disease Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 206010046914 Vaginal infection Diseases 0.000 description 1
- 201000008100 Vaginitis Diseases 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 208000000260 Warts Diseases 0.000 description 1
- 206010048259 Zinc deficiency Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- DPWSRXJWCYEGIV-CWMZTGDLSA-N acetic acid;n-[(2s)-1-[[(2s)-1-[[(2s)-1-[[(2s)-1-[[(2r)-1-[[(2s)-1-[[(2s)-5-(diaminomethylideneamino)-1-[(2s)-2-(ethylcarbamoyl)pyrrolidin-1-yl]-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-1-oxopropan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxoprop Chemical compound CC(O)=O.CC(O)=O.CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](C)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)C1NC(=O)CC1)CC1=CC=C(O)C=C1 DPWSRXJWCYEGIV-CWMZTGDLSA-N 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 239000011149 active material Substances 0.000 description 1
- 229960005305 adenosine Drugs 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- 206010064930 age-related macular degeneration Diseases 0.000 description 1
- 231100000360 alopecia Toxicity 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 230000004596 appetite loss Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000037444 atrophy Effects 0.000 description 1
- 235000008452 baby food Nutrition 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000007698 birth defect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 230000003139 buffering effect Effects 0.000 description 1
- 235000017663 capsaicin Nutrition 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 210000004413 cardiac myocyte Anatomy 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000021617 central nervous system development Effects 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- BHQCQFFYRZLCQQ-OELDTZBJSA-N cholic acid Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 BHQCQFFYRZLCQQ-OELDTZBJSA-N 0.000 description 1
- 229960002471 cholic acid Drugs 0.000 description 1
- 235000019416 cholic acid Nutrition 0.000 description 1
- 239000004927 clay Substances 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 230000003412 degenerative effect Effects 0.000 description 1
- KXGVEGMKQFWNSR-UHFFFAOYSA-N deoxycholic acid Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 KXGVEGMKQFWNSR-UHFFFAOYSA-N 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 208000030172 endocrine system disease Diseases 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 230000035558 fertility Effects 0.000 description 1
- 210000003754 fetus Anatomy 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 108010038983 glycyl-histidyl-lysine Proteins 0.000 description 1
- 210000002149 gonad Anatomy 0.000 description 1
- 229940032584 grape seed extract 60 mg Drugs 0.000 description 1
- 238000009499 grossing Methods 0.000 description 1
- 231100000001 growth retardation Toxicity 0.000 description 1
- 230000003676 hair loss Effects 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 239000000185 hemagglutinin Substances 0.000 description 1
- 208000014951 hematologic disease Diseases 0.000 description 1
- 208000018706 hematopoietic system disease Diseases 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 239000000413 hydrolysate Substances 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 206010020718 hyperplasia Diseases 0.000 description 1
- 208000034783 hypoesthesia Diseases 0.000 description 1
- 235000019570 hypogeusia Nutrition 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 210000003016 hypothalamus Anatomy 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 230000016784 immunoglobulin production Effects 0.000 description 1
- 230000007365 immunoregulation Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 208000023589 ischemic disease Diseases 0.000 description 1
- 230000000302 ischemic effect Effects 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 150000002561 ketenes Chemical class 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 230000037356 lipid metabolism Effects 0.000 description 1
- 230000003859 lipid peroxidation Effects 0.000 description 1
- 201000007270 liver cancer Diseases 0.000 description 1
- 208000014018 liver neoplasm Diseases 0.000 description 1
- 235000021266 loss of appetite Nutrition 0.000 description 1
- 208000019017 loss of appetite Diseases 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 208000002780 macular degeneration Diseases 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000002398 materia medica Substances 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 210000003632 microfilament Anatomy 0.000 description 1
- 239000011785 micronutrient Substances 0.000 description 1
- 235000013369 micronutrients Nutrition 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 210000000663 muscle cell Anatomy 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 208000001491 myopia Diseases 0.000 description 1
- 230000004379 myopia Effects 0.000 description 1
- 239000005445 natural material Substances 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 208000001749 optic atrophy Diseases 0.000 description 1
- 210000004798 organs belonging to the digestive system Anatomy 0.000 description 1
- 201000008482 osteoarthritis Diseases 0.000 description 1
- 210000004409 osteocyte Anatomy 0.000 description 1
- 230000001151 other effect Effects 0.000 description 1
- 230000002611 ovarian Effects 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- 230000027758 ovulation cycle Effects 0.000 description 1
- VWMVAQHMFFZQGD-UHFFFAOYSA-N p-Hydroxybenzyl acetone Natural products CC(=O)CC1=CC=C(O)C=C1 VWMVAQHMFFZQGD-UHFFFAOYSA-N 0.000 description 1
- 230000000242 pagocytic effect Effects 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 210000003635 pituitary gland Anatomy 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 201000010065 polycystic ovary syndrome Diseases 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 206010036596 premature ejaculation Diseases 0.000 description 1
- 208000026440 premature labor Diseases 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 238000011321 prophylaxis Methods 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 208000020016 psychiatric disease Diseases 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- NJGBTKGETPDVIK-UHFFFAOYSA-N raspberry ketone Chemical compound CC(=O)CCC1=CC=C(O)C=C1 NJGBTKGETPDVIK-UHFFFAOYSA-N 0.000 description 1
- 230000009103 reabsorption Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 230000003716 rejuvenation Effects 0.000 description 1
- 210000004994 reproductive system Anatomy 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- IKGXIBQEEMLURG-NVPNHPEKSA-N rutin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-NVPNHPEKSA-N 0.000 description 1
- 238000007665 sagging Methods 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- 108010048734 sclerotin Proteins 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 230000008054 signal transmission Effects 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 210000002027 skeletal muscle Anatomy 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 201000010153 skin papilloma Diseases 0.000 description 1
- 230000003860 sleep quality Effects 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 235000011496 sports drink Nutrition 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- WBWWGRHZICKQGZ-HZAMXZRMSA-N taurocholic acid Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(=O)NCCS(O)(=O)=O)C)[C@@]2(C)[C@@H](O)C1 WBWWGRHZICKQGZ-HZAMXZRMSA-N 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 229960003604 testosterone Drugs 0.000 description 1
- 210000001685 thyroid gland Anatomy 0.000 description 1
- 208000021510 thyroid gland disease Diseases 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 125000002640 tocopherol group Chemical group 0.000 description 1
- 235000015961 tonic Nutrition 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 229960000716 tonics Drugs 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 208000000143 urethritis Diseases 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 210000002229 urogenital system Anatomy 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 238000011121 vaginal smear Methods 0.000 description 1
- 229940124549 vasodilator Drugs 0.000 description 1
- 239000003071 vasodilator agent Substances 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 210000003905 vulva Anatomy 0.000 description 1
- 235000013618 yogurt Nutrition 0.000 description 1
- 235000021247 β-casein Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/385—Concentrates of non-alcoholic beverages
- A23L2/39—Dry compositions
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L31/00—Edible extracts or preparations of fungi; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/19—Dairy proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Inorganic Chemistry (AREA)
- Botany (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
本发明提供了用于女士保健的固体饮料,其原料成分包括复合氨基酸、植物提取物、微量元素、复合维生素及调味品,复合氨基酸为55%‑70%,调味品为14%‑24%,植物提取物为14%‑24%,微量元素为0.1%‑1%,复合维生素为0.01%‑0.1%;复合氨基酸中,海洋鱼低聚肽粉:乳清蛋白粉:牛磺酸=0.8:6:0.01;植物提取物中,葛根提取物:(覆盆子提取物+枸杞子提取物):(硒虫草提取物+葡萄籽提取物)=2:4:1.1;硒虫草提取物内的有机硒:乳酸锌:甘氨酸钙=0.01:1:20;维生素E:β‑胡萝卜素=100:3。本发明各组分合理复配,提高免疫力、平衡女性荷尔蒙、抗衰老、调节女性生理机能。
Description
技术领域
本发明涉及中药及保健食品领域,尤其涉及一种用于女士保健的固体饮料及其制备方法。
背景技术
现代社会,由于生活节奏快,饮食起居无规律,工作压力大,环境污染等饮食,造成女性特别是中老年妇女容易出现神疲乏力、雌激素水平下降、营养素流失加速致使内分泌紊乱,引起一系列亚健康问题如更年期综合征、性冷淡、衰老加速、骨质疏松及心脑血管病变等。第一,女人在更年期到来之后,随着新陈代谢的逐渐下降,最典型的症状是月经改变和潮热:这是女性更年期综合症的严重表现,也是最常见的两种表现,严重的可能会引起盗汗、贫血、失眠等不适症状,极大地降低了正常的生活质量。第二、心脑血管:表现为胸闷、心慌气短、血压波动、眩晕眼花等。因为雌激素的水平降低,所以使血中胆固醇升高容易发生动脉粥样硬化、心肌梗塞、心肌缺血、高血压等症状;第三、泌尿生殖系统:因雌激素水平降低,出现阴道干涩、性欲减退、性交痛,外阴痒、阴道炎、尿道炎、尿频等症状;第四、骨骼肌肉:骨质疏松,颈、腰酸背痛,抽筋,关节疼痛、易发生骨折等;第五、女人更年期最普遍会出现面部毛孔粗大,脸上色斑沉淀越来越明显;第六、随着年龄的增加机体的新陈代谢能力会不断下降,尤其是上了年纪的女人运动量也逐渐减少,这些都会导致身体脂肪堆积,热量消耗减少,从而导致身体肥胖情况的出现;第七、女人处于更年期的时候精神方面会出现改变,疲劳、头痛、头晕、激动易怒、抑郁、思想难以集中等等都是典型特征,严重的还容易出现心理疾病。
一直以来,固体饮料因品种多样、风味独特、易于存放而备受消费者青睐;尤其是那些富含维生素、矿物质、氨基酸等营养成分的固体饮料,可以及时补充人体代谢所需营养,更成为了许多人生活中离不开的好伴侣。但是,现有的固体饮料的糖类、胆固醇含量较高,使饮用者造成不同程度的肥胖、糖药病等症状更加普遍。还有,市场上还没有针对女性特别是中老年妇女的亚健康问题的多方面调理的固体饮料。因此,如何研发出一种更加绿色、健康的女性固体饮料成为新的课题。
发明内容
本发明的目的在于提供一种用于女士保健的固体饮料及其制备方法,通过补充女性重要营养素,一是改善一些重要生物酶的合成及活性;二是调节机体代谢过程;三是通过补充蛋白质及含有葛根异黄酮、虫草素等活性成分的中草药提取物,从而达到提高免疫力、抗氧化、抗衰老、平衡女性荷尔蒙、调节女性生理机能,美容、防治更年期综合征、防治性冷淡、防治骨质疏松的作用;本发明配方除了将各原料的固有性质得以发挥之外,通过它们之间的配合关系还得到了营养成分的成倍提高和口感的改善,真正实现了大健康的研发理念。
本发明解决其技术问题是采用以下技术方案来实现的:
本发明提供一种用于女士保健的固体饮料,其原料成分包括复合氨基酸、植物提取物、微量元素、复合维生素及调味品,各组分占总原料中的比重,复合氨基酸为55%-70%,调味品为14%-24%,植物提取物为14%-24%,微量元素为0.1%-1%,复合维生素为0.01%-0.1%;
所述复合氨基酸包括海洋鱼低聚肽粉、乳清蛋白粉和牛磺酸,且海洋鱼低聚肽粉:乳清蛋白粉:牛磺酸=0.8:6:0.01;
所述植物提取物包括葛根提取物、覆盆子提取物、枸杞子提取物、硒虫草提取物和葡萄籽提取物,且葛根提取物:(覆盆子提取物+枸杞子提取物):(硒虫草提取物+葡萄籽提取物)=2:4:1.1;
所述微量元素包括乳酸锌和甘氨酸钙,所述硒虫草提取物里含有有机硒,且所述有机硒:乳酸锌:甘氨酸钙=0.01:1:20;
所述复合维生素包括维生素E和β-胡萝卜素,且维生素E:β-胡萝卜素=100:3。
本发明还提供一种如上任一所述的用于女士保健的固体饮料的制备方法,包括如下步骤:
步骤1、备料混料:按如上任一所述的重量百分比含量称取各原料组分,除调味品外的所有原料成分进行混合;
步骤2、制粒:加入调味品进行调味和制粒,使其均匀形成颗粒。
步骤3、灭菌干燥:将步骤2得到的颗粒灭菌,并于30-60℃温度下干燥至水分含量<3%,得到中间体粉料;
步骤4、包装:将步骤3中所得的将中间体粉料进行检验,之后进行内包装、外包装,最后进行成品检验后入库。
本发明中各主要原料药的功效活性如下:
1、硒虫草提取物:主要成分为有机硒、虫草素、虫草酸、虫草多糖等。硒虫草是选用北冬虫夏草菌株以及恩施天然硒资源,采用生物组培技术培育出的富含生命必须微量元素硒的虫草子实体,产品把虫草与硒有机结合,硒含量稳定可靠,且90%以上以有机状态存在,营养成分更全面,生物学作用更强。虫草素(cordycepin)是虫草最主要的活性成分,作为一种天然来源的物质,具有免疫调节作用、抗肿瘤作用、抗菌抗病毒作用、抗炎作用、抗白血病作用。虫草酸(即D-甘露醇),是一种甘露糖醇,是硅宁酸的异构物。甘露醇经肾小球滤过后在肾小管内很少被重吸收,可提高肾小管内液渗透浓度,起到渗透利尿作用。临床证明虫草酸可预防与治疗脑血栓、脑出血、心肌梗塞;还具有促进人体新陈代谢,改善人体微循环系统,降低血脂,平喘的功效。虫草多糖是由甘露糖、腺苷、半乳糖、阿拉伯糖、木糖精、葡萄糖、岩藻糖组成的多聚糖,为白色粉末,无异味,易溶于水。实验证明天然虫草及人工虫草菌丝体中所含有的虫草多糖都具有广泛药理作用。虫草多糖可活化巨噬细胞刺激抗体产生,提高人体免疫能力;并具有抗肿瘤、抗辐射、降血糖和脂蛋白、止咳、化痰、润肺和延缓衰老等药理作用。因此硒虫草具有防癌、抗辐射、抗衰老、调节免疫、滋阴补阳、改善人体机能等作用。是一款高端硒营养滋补品。适宜人群:慢性、消耗性疾病(如癌症、结核)的营养滋补;亚健康状况人群的营养调节;对硒缺乏相关疾病的预防(如克山病、大骨节病、心脑血管病、肿瘤等)。
2、葛根提取物:主要活性成分为葛根黄酮和葛根异黄酮。葛根黄酮具有提高免疫,增强心肌收缩力,保护心肌细胞,降低血压,抗血小板聚集等作用。葛根异黄酮是目前在分子结构上与人体自身分泌的雌激素最为相似的一种植物雌激素,因此,它能与身体各系统、器官组织细胞表面的雌激素受体结合,发挥效应。与其它调节女性内分泌的药物相比,葛根异黄酮的独特之处在于具有与体内雌激素受体抢先结合和作用温和两个特点,还具有抗癌、预防动脉硬化、改善骨质疏松等作用。调节体内雌激素平衡是维持女性特征、保持青春的根本,葛根异黄酮优于其它植物雌激素的地方在于,它不是无止境的补充雌激素,而是达到符合人体标准的一个量,所以,服食葛根异黄酮,不会出现雌激素过浓的症状。其安全性是雌激素产品中最佳的。青春期女性:月经不调、痛经、皮肤粗糙、乳房发育不良。适宜人群:育龄期女性:月经不调,不孕(慢性无排卵)、多毛、肥胖、卵巢增生等多囊卵巢综合症。产后女性:生完孩子的女性乳房松弛、下垂、脸上长满斑点。年近40岁:体胖失形、月经开始紊乱,将要或刚进入更年期的女性。更年期女性:潮热出汗、心烦易怒、失眠多梦、焦躁不安、血脂异常等。停经多年、老年女性:由于停经导致雌激素下降,出现高血压、高血脂、糖尿病、心肌缺血、骨质疏松、记忆力减退等。妇科疾病:阴道干涩、性交疼痛、性生活不和谐。切除子宫或卵巢:患者在配合临床治疗的前提下,补充葛根异黄酮。
3、覆盆子提取物:覆盆子功能为益肾,固精,缩尿。用于肾虚遗尿,小便频数,阳痿早泄,遗精滑精。抗衰老:覆盆子含有多种抗氧化、调节免疫功能和调整物质代谢等作用的成分。近年来有人从100个抗衰延寿古方中进行筛选,并通过寿命实验,结果表明覆盆子为作用最为显着的7味中药之一。改善性冷淡:覆盆子能增强下丘脑-垂体-性腺轴功能而具有延年益寿之功。它是常见的补肾中药之一。覆盆子水提取液能降低下丘脑的LHRH,垂体LH、FSH及性腺E2的水平,升高睾酮水平,它对性腺轴的调控作用可能是其“补肾涩精”的药理基础。药理实验研究表明,覆盆子具有抑菌和类雌激素作用,以兔的阴道涂片及内膜切片作观察指标,覆盆子似有雌激素样作用。免疫调节:覆盆子的四种提取成份:水提取液、醇提取液、粗多糖和正丁醇组分具有明显的淋巴细胞增殖作用,覆盆子水醇提取液具有类似植物血凝素的作用。从而能提高细胞免疫功能,达到防癌的作用。经实验证实,覆盆子是抗肝癌HepG2细胞增殖能力的和抑制HepG2细胞PCNA表达能力最强的药食两用水果。覆盆子水提取液中具有促进胸腺内某些细胞合成LHRH样物质的作用。有报道,LHRH及其类似物LHRH-A具有促进胸腺细胞增殖和改善老年大鼠胸腺衰退的作用,故促进胸腺LHRH可能是覆盆子水提取液促进细胞免疫机能的途径之一。减肥:含有烯酮素(raspberry ketone),能够加速脂肪的代谢燃烧,效果比辣椒素(Capsaicin)强三倍,比平常进食加快5倍脂肪代谢燃烧。
4、葡萄籽提取物
葡萄籽提取物是从葡萄籽中提取的一种人体内不能合成的新型高效天然抗氧化剂物质。它是目前自然界中发现的抗氧化、清除自由基能力最强的物质,其抗氧化活性为维生素E的50倍、维生素C的20倍,它能有效清除人体内多余的自由基,具有超强的延缓衰老和增强免疫力的作用。抗氧化、抗过敏、抗疲劳增强体质、改善亚健康状态延缓衰老、改善烦躁易怒、头昏乏力、记忆力减退等症状。体内和体外试验表明,葡萄籽提取物"原花青素OPC"的抗氧化效果,是维生素C和维生素E的50-70倍。超强的抗氧化效率具有清除自由基、提高人体免疫力的强力效果。葡萄籽精华(Grape Seed Extract)含丰富生物类黄酮、是强力的精华分子,用于对抗自由基(游离基)与维护微丝血管的健康。(自由基是造成老化及诸多疾病的重要原因之一,具估计大约80%-90%的老化性、退化性疾病都与自由基有关,所以,葡萄籽提取物对人体抗氧化,提高免疫力有极佳的效果。被誉为"皮肤维生素"、"口服化妆品"。
5、薏苡仁提取物:薏苡仁是极佳的美容食材,具有治疣平痘、淡斑美白、润肤除皱等美容养颜功效,尤其是所含的蛋白质分解酵素能使皮肤角质软化,维生素E有抗氧化作用。《本草纲目》谓薏苡仁"健脾益胃,补肺清热、祛风胜湿,养颜驻容、轻身延年"。
6、海洋鱼低聚肽粉:食物中的胶原蛋白,其分子量大约40-60万道尔顿,很难被人体消化吸收。即使是完全煮化了的牛筋汤、鱼皮汤、猪蹄汤,人体的吸收率也仅为20%左右。只有低分子量的肽粉,才能被人体充分吸收。分子量在1000-3000道尔顿以下的肽为低聚肽。低聚肽的稳定性远远优于普通胶原蛋白分子。他们具有更耐热、耐酸碱、不容易变性的优点,而且不需要经过胃肠道消化分解而能直接为人体吸收,减轻肾脏代谢负担,为您提供更优质、更易吸收的优质蛋白。作用:(1)能够有效解决皮肤及肌肉水分减少问题,适时补充胶原肽,能使皮肤保持年轻。(2)使钙质与骨细胞紧密结合,不会流失或退化。(3)能使眼角膜保持湿润透明,增加眼睛透明度。(4)促使肌肉细胞紧密连结,使其具有弹性及光泽。(5)调节内分泌、保护及强化内脏功能。(6)结合免疫球蛋白,增加免疫力。
7、酪蛋白磷酸肽:酪蛋白磷酸肽(CPP)是以牛乳酪蛋白为原料,通过生物技术制得的具有生物活性的多肽,可用于各种营养、保健食品中,能有效促进人体对钙、铁、锌等二价矿物营养素的吸收和利用。酪蛋白磷酸肽,由牛乳酪蛋白水解而得,可以促进钙、铁、锌、镁等矿物质的吸收和利用,使骨量增加。
酪蛋白磷酸肽(Casein Phosphopeptides,CPP)是功能性食品添加剂的一种,按日本厚生省分类属于氨基酸系列。它的蛋白前体是α、β-酪蛋白,其生理功能是促进钙、锌、铁的吸收,抗蛀牙、提高动物受精能力,调节血压。
8、牛磺酸:又称β-氨基乙磺酸,最早由牛黄中分离出来,故得名。(1)保护视网膜:牛磺酸占视网膜中游离氨基酸总量的50%,动物实验证明,缺乏牛磺酸的猫其视网膜电图显示杆细胞与锥细胞广泛变性。促进中枢神经系统发育胎儿发育中脑组织的浓度显著高于出生后,提示牛磺酸对中枢神经系统发育,如细胞的增殖、移行与分化有作用。(2)保护心肌作用:牛磺酸有增强心脏收缩力的作用。可对抗毛地黄引起的心律不齐,这可能与牛磺酸对膜通透性以及离子流的作用,维持细胞内钙离子浓度有关。牛磺酸还有提高心肌耐缺氧能力作用。(3)抗氧化作用:牛磺酸有维护许多细胞,特别是血细胞抗氧化活性,使组织免受氧化基与自由基的损伤。(4)促进免疫功能:牛磺酸有提高细胞免疫吞噬功能,促进免疫球蛋白的生成的作用。(5)促进脂类消化吸收:牛磺酸与胆酸结合成牛磺胆酸,参与脂类的消化吸收。牛磺酸有降低血小板聚集作用,有增强精子的运动能力,以及提高胰岛素的活性等。(6)维持正常的生殖功能,有资料证实,猫饲料中牛磺酸含量低于0.101%时,其生殖功能不良,死胎、流产和先天缺陷率增高,幼仔存活率下降。含0.105%以上时,才能维持正常的生殖功能。
9、乳酸锌:锌是人体必需的微量元素之一,在人体生长发育、生殖遗传、免疫、内分泌等重要生理过程中起着极其重要的作用,被人们冠以“生命之花”、“智力之源”、“婚姻和谐素”的美称。锌存在于众多的酶系中,如碳酸酐酶、呼吸酶、乳酸脱氢酸、超氧化物歧化酶、碱性磷酸酶、DNA和RNA聚中酶等中,是核酸、蛋白质、碳水化合物的合成和维生素A利用的必需物质。具有促进生长发育,改善味觉的作用。锌缺乏容易引起食欲不振、味觉减退、嗅觉异常、生长迟缓、侏儒症,智力低下、溃疡、皮节炎、脑腺萎缩、免疫功能下降、生殖系统功能受损,创伤愈合缓慢、容易感冒、流产、早产、生殖无能、头发早白、脱发、视神经萎缩、近视、白内障、老年黄斑变性、老年人加速衰老、缺血症、毒血症、肝硬化。锌是人体必需的微量元素,它以蛋白质和金属酶的形式存在于人体,锌具有加速生长发育,改善味觉、调节机体、免疫、防止感染和促进伤口愈合等功能[1]。甘氨酸在体内可以转换成多种重要的活性物质和其它人体必需的氨基酸,还具有缓冲、制酸等作用,用于治疗胃酸过多等。由于氨基酸所特有的生理功能,它与锌的配合物,随着人体对氨基酸的吸收,锌也被吸收,会产生有利于人体的协同作用,两者有很好的配伍性,且甘氨酸锌有利于小肠的主动吸收,在体外将甘氨酸及锌结合成稳定的甘氨酸锌,可不受事物其它因素的影响,整体吸收,有一定的杀菌作用和相当的营养作用。
10、甘氨酸钙:好溶解,吸收率高可用于强化儿童食品、保健品和运动饮料,同样因为溶解度高,可配制成果味、高钙浓缩液,用于制造酸乳。可作为食品的钙强化剂与营养剂,有助于骨质的形成,并能维持神经和肌肉的正常兴奋性,同时还可用于缓冲剂、固化剂。为具有营养和治疗双重作用的补钙制剂。
11、β一胡萝卜素:摄入人体消化器官后,可以转化成维生素A,是目前最安全补充维生素A的产品它可以维持眼睛和皮肤的健康,改善夜盲症、皮肤粗糙的状况,有助于身体免受自由基的伤害。β一胡萝卜素主要具有以下生理功能:①抗氧化的功能,能淬灭单线态氧和清除体内自由基,对脂质过氧化有抑制作用,防止视网膜的光损伤。②是维生素A的前体,维生素A是人体必需的微量营养素。③免疫功能,能提高人体免疫力。④能预防癌症,延缓癌症的发展。⑤能促进细胞间联结交流,间隙连接是细胞间的一种重要连接方式,它允许分子量为1000一1600Pa以下的离子或小分子通过,从而保证细胞间正常生长控制信号的传递。⑥能增强胰岛素的敏感性,降低糖尿病的发病率。
12、维生素E(Vitamin E)是一种脂溶性维生素,其水解产物为生育酚,是最主要的抗氧化剂之一。主要功效为:有效减少皱纹的产生,保持青春的容貌;减少细胞耗氧量,使人更有耐久力,有助减轻腿抽筋和手足僵硬的状况;抗氧化保护机体细胞免受自由基的毒害;改善脂质代谢,预防冠心病硬化;抗衰老和抗癌,预防器质性衰退疾病的佳品;预防炎症性皮肤病、脱发症。改善性冷淡、月经不调、不孕;身体内保护器官强力抗氧化剂;抑制脂质过氧化及形成自由基。调整荷尔蒙、活化脑下垂体;预防治疗甲状腺疾病(甲状腺分泌过量或过少);改善血液循环、保护组织、降低胆固醇、预防高血压。是一种很重要的血管扩张剂和抗凝血剂;延缓衰老、预防癌症、预防多处慢性疾病;保护皮肤免受紫外线和污染的伤害,减少疤痕与色素的沉积;对激素的合成有重要作用。
本发明具有以下有益效果:
1、本发明提供的用于女士保健的固体饮料中,微量元素(硒锌钙等)促进钙、锌、铁吸收的酪蛋白磷酸肽等,是机体抗氧化酶、碳酸酐酶、DNA聚合酶、RNA聚合酶等许多酶合成及活性发挥的必须元素;复合维生素(β-胡萝卜素、维生素E等)参与机体代谢的调节,是维持人体生命活动必须的一类有机物质;植物提取物(虫草、葛根、枸杞子、覆盆子、薏苡仁、葡萄籽提取物等)大都具有提高免疫力、抗氧化、抗衰老等作用;胶原蛋白、酪蛋白、乳清蛋白等高级蛋白物质及牛磺酸等条件氨基酸的补充则为机体及其生命活动提供了最基本的物质基础。总之,本发明通过补充女性重要营养素。一是改善一些重要生物酶的合成及活性;二是调节机体代谢过程;三是通过补充蛋白质及含有葛根异黄酮、虫草素等活性成分的中草药提取物,达到提高免疫力、抗氧化、抗衰老、平衡女性荷尔蒙、调节女性生理机能,美容、防治更年期综合征、防治性冷淡、防治骨质疏松的作用。各组分复配协同增效,各组分的合理的复配,能够调整身体阴阳平衡、对改善女性亚健康状态有着积极作用;
2、本发明提供的用于女士保健的固体饮料中的植物提取物中,之所以将葛根提取物、(覆盆子提取物+枸杞子提取物)、(硒虫草提取物+葡萄籽提取物)这样区分开来,是因为它们的作用类似却不完全相同,其中葛根中的异黄酮具有类雌激素样作用,籍以调节女性内分泌失衡;枸杞子、覆盆子具有抗衰老、防止性冷淡功能,硒虫草、薏苡仁、葡萄籽具有对抗自由基、抗衰老、美容等作用,且所述硒虫草提取物主要成分为有机硒、虫草素、虫草酸、虫草多糖等。硒虫草是选用北冬虫夏草菌株以及恩施天然硒资源,采用生物组培技术培育出的富含生命必须微量元素硒的虫草子实体,产品把虫草与硒有机结合,硒含量稳定可靠,且90%以上以有机状态存在,营养成分更全面,生物学作用更强。硒虫草具有防癌、抗辐射、抗衰老、调节免疫、滋阴补阳、改善人体机能等作用。所述硒虫草提取物里含有有机硒,且所述有机硒:乳酸锌:甘氨酸钙=0.01:1:20,钙铁锌硒作为人体所需的重要微量元素,中老年妇女赋予不需要特别补充铁,硒、锌、钙的比例也是本申请另一大特点,符合人体所需微量元素的黄金比例;各组分除了将各原料的固有性质得以发挥之外,通过它们之间的配合关系还得到了意料不到的口感效果及营养成分的成倍提高,真正实现了大健康的研发理念。
具体实施方式
实施例1
步骤1:备料
(一)植物提取物(共4.55g):葛根提取物1g;枸杞子提取物1g、覆盆子提取物1g;硒虫草提取物0.5g(有机硒0.05mg)、薏苡仁提取物1g、葡萄籽提取物50mg;
(二)复合维生素(共5.15mg):维生素E 5mg;β-胡萝卜素0.15mg;
(三)复合氨基酸(共17.025g):海洋鱼低聚肽粉2g;乳清蛋白粉15g;牛磺酸25mg;
(四)微量元素(共105mg):乳酸锌5mg;甘氨酸钙100mg;
(五)调味品5g;
步骤2、混料:按如上的重量百分比含量称取各原料组分,除调味品外的所有原料成分进行混合;
步骤3、制粒:加入调味品进行调味和粉碎制粒,使其均匀形成颗粒。
步骤4、灭菌干燥:将步骤3得到的颗粒灭菌,并于30-60℃温度下干燥至水分含量<3%,得到中间体粉料;
步骤5、包装:将步骤4中所得的将中间体粉料进行检验,之后进行内包装、外包装,最后进行成品检验后入库。
实施例2
(一)植物提取物(共3.55g):葛根提取物1g;枸杞子提取物1g、覆盆子提取物1g;硒虫草提取物0.5g(有机硒0.05mg)、葡萄籽提取物50mg;
(二)复合维生素(共5.15mg):维生素E 5mg;β-胡萝卜素0.15mg;
(三)复合氨基酸(共17.025g):海洋鱼低聚肽粉2g;乳清蛋白粉15g;牛磺酸25mg;
(四)微量元素(共105mg):乳酸锌5mg;甘氨酸钙100mg;
(五)调味品4g;其他步骤同实施例1。
实施例3
(一)植物提取物(共5.005g):葛根提取物1.1g;枸杞子提取物1.1g、覆盆子提取物1.1g;硒虫草提取物0.55g(有机硒0.055mg;)、薏苡仁提取物1.1g、葡萄籽提取物55mg;
(二)复合维生素(共7.725mg):维生素E 7.5mg;β-胡萝卜素0.225mg;
(三)复合氨基酸(共15.325g):海洋鱼低聚肽粉1.8g;乳清蛋白粉13.5g;牛磺酸25mg;
(四)微量元素(共115.5mg):乳酸锌5.5mg;甘氨酸钙110mg;
(五)调味品6.2324g;其他步骤同实施例1。
实施例4
(一)植物提取物(共5.46g):葛根提取物1.2g;枸杞子提取物1.2g、覆盆子提取物1.2g;硒虫草提取物0.6g(有机硒0.06mg)、薏苡仁提取物1.2g、葡萄籽提取物60mg;
(二)复合维生素(共7.725mg):维生素E 7.5mg;β-胡萝卜素0.225mg;
(三)复合氨基酸(共15.325g):海洋鱼低聚肽粉1.8g;乳清蛋白粉13.5g;牛磺酸25mg;
(四)微量元素(共126mg):乳酸锌6mg;甘氨酸钙120mg;
(五)调味品5.7609gg;其他步骤同实施例1。
实施例5
(三)植物提取物(共5.915g):葛根提取物1.3g;枸杞子提取物1.3g、覆盆子提取物1.3g;硒虫草提取物0.65g(有机硒0.065mg)、薏苡仁提取物1.3g、葡萄籽提取物65mg;
(四)复合维生素(共7.725mg):维生素E 7.5mg;β-胡萝卜素0.225mg;
(三)复合氨基酸(共15.325g):海洋鱼低聚肽粉1.8g;乳清蛋白粉13.5g;牛磺酸25mg;
(四)微量元素(共136.5mg):乳酸锌6.5mg;甘氨酸钙130mg;
(五)调味品5.2989g;其他步骤同实施例1。
实施例1-5中,所述调味品包括蜂蜜,蜂蜜是纯天然的保健饮料特别适合女士饮用,具有抗衰老、抗癌、滋补强壮、提高睡眠质量、调节内分泌、养血补血、美容嫩肤、降三高、保持女性青春活力的等功效。
实施例1-5的具体配方组分见表1
表1
原料 | 实施例1 | 实施例2 | 实施例3 | 实施例4 | 实施例5 |
葛根提取物 | 1g | 1g | 1.1g | 1.2g | 1.3g |
覆盆子提取物 | 1g | 1g | 1.1g | 1.2g | 1.3g |
枸杞子提取物 | 1g | 1g | 1.1g | 1.2g | 1.3g |
硒虫草提取物 | 0.5g | 0.5g | 0.55g | 0.6g | 0.65g |
葡萄籽提取物 | 50mg | 50mg | 55mg | 60mg | 65mg |
薏苡仁提取物 | 1g | 0mg | 1.1g | 1.2g | 1.3g |
海洋鱼低聚肽粉 | 2g | 2g | 1.8g | 1.8g | 1.8g |
乳清蛋白粉 | 15g | 15g | 13.5g | 13.5g | 13.5g |
牛磺酸 | 25mg | 25mg | 22.5mg | 22.5mg | 25mg |
乳酸锌 | 5mg | 5mg | 5.5mg | 6mg | 6.5mg |
甘氨酸钙 | 100mg | 100mg | 110mg | 120mg | 130mg |
维生素E | 5mg | 5mg | 7.5mg | 7.5mg | 7.5mg |
β-胡萝卜素 | 0.15mg | 0.15mg | 0.225mg | 0.225mg | 0.225mg |
调味品 | 5g | 4g | 6.2324g | 5.7609g | 5.2989g |
总量 | 26.68515g | 26.68515g | 26.68515g | 26.68515g | 26.68515g |
应用例
本实施例1-5的用于女士保健的固体饮料,其用法和用量为每天一至两次,每次15克,可以直接食用,也可以开水泡服。
应用本实施例的植物保健固体饮料给予亚健康女士特别是45-55岁的中老年妇女食用,其效果如表2所示,表2中的人群的使用剂量为10-15克/天,疗程为90天。
表2
从表2可以看出,本实施例的用于女士保健的固体饮料调整身体阴阳平衡、对改善亚健康状态有明显的改善作用。微量元素(硒锌钙等)促进钙、锌、铁吸收的酪蛋白磷酸肽等,是机体抗氧化酶、碳酸酐酶、DNA聚合酶、RNA聚合酶等许多酶合成及活性发挥的必须元素;复合维生素(β-胡萝卜素、维生素E等)参与机体代谢的调节,是维持人体生命活动必须的一类有机物质;植物提取物(虫草、葛根、枸杞子、覆盆子、薏苡仁、葡萄籽提取物等)大都具有提高免疫力、抗氧化、抗衰老等作用;胶原蛋白、酪蛋白、乳清蛋白等高级蛋白物质及牛磺酸等条件氨基酸的补充则为机体及其生命活动提供了最基本的物质基础。总之,本发明通过补充女性重要营养素。一是改善一些重要生物酶的合成及活性;二是调节机体代谢过程;三是通过补充蛋白质及含有葛根异黄酮、虫草素等活性成分的中草药提取物,达到提高免疫力、抗氧化、抗衰老、平衡女性荷尔蒙、调节女性生理机能,美容、防治更年期综合征、防治性冷淡、防治骨质疏松的作用。各组分复配协同增效,各组分的合理的复配,能够调整身体阴阳平衡、对改善女性亚健康状态有着积极作用;
以上所述仅为本发明的较佳实施例而已,并不用以限制本发明,凡在本发明的精神和原则之内,所作的任何修改、等同替换、改进等,均应包含在本发明的保护范围之内。
Claims (7)
1.一种用于女士保健的固体饮料,其特征在于,其原料成分包括复合氨基酸、植物提取物、微量元素、复合维生素及调味品,各组分占总原料中的比重,复合氨基酸为55%-70%,调味品为14%-24%,植物提取物为14%-24%,微量元素为0.1%-1%,复合维生素为0.01%-0.1%;
所述复合氨基酸包括海洋鱼低聚肽粉、乳清蛋白粉和牛磺酸,且海洋鱼低聚肽粉:乳清蛋白粉:牛磺酸=0.8:6:0.01;
所述植物提取物包括葛根提取物、覆盆子提取物、枸杞子提取物、硒虫草提取物和葡萄籽提取物,且葛根提取物:(覆盆子提取物+枸杞子提取物):(硒虫草提取物+葡萄籽提取物)=2:4:1.1;
所述微量元素包括乳酸锌和甘氨酸钙,所述硒虫草提取物里含有有机硒,且所述有机硒:乳酸锌:甘氨酸钙=0.01:1:20;
所述复合维生素包括维生素E和β-胡萝卜素,且维生素E:β-胡萝卜素=100:3。
2.如权利要求1所述的用于女士保健的固体饮料,其特征在于,所述复合氨基酸中的各组分占总原料成分中的比重,海洋鱼低聚肽粉为4-10%,乳清蛋白粉为50-60%,牛磺酸为0.05-0.15%。
3.如权利要求1所述的用于女士保健的固体饮料,其特征在于,所述植物提取物中还包括薏苡仁提取物,且葛根提取物:(覆盆子提取物+枸杞子提取物):(硒虫草提取物+薏苡仁提取物+葡萄籽提取物)=2:4:3.1。
4.如权利要求3所述的用于女士保健的固体饮料,其特征在于,所述植物提取物中的各组分占总原料成分中的比重,葛根提取物为2-5%,覆盆子提取物为2-5%,枸杞子提取物为2-5%,薏苡仁提取物为2-5%,硒虫草提取物为1-3%,葡萄籽提取物为0.1-0.3%。
5.如权利要求1所述的用于女士保健的固体饮料,其特征在于,所述微量元素中的各组分占总原料成分中的比重,乳酸锌为0.01-0.03%,甘氨酸钙为0.1-0.6%,且硒虫草提取物里的有机硒为0.00001-0.00003%。
6.如权利要求1所述的用于女士保健的固体饮料,其特征在于,所述复合维生素中的各组分占总原料成分中的比重,维生素E为0.01-0.03%,β-胡萝卜素为0.0003%-0.0009%。
7.一种如权利要求1-6任一所述的用于女士保健的固体饮料的制备方法,其特征在于,包括如下步骤:
步骤1、备料混料:按如权利要求1-6任一所述的重量百分比含量称取各原料组分,除调味品外的所有原料成分进行混合;
步骤2、制粒:加入调味品进行调味和粉碎制粒,使其均匀形成颗粒。
步骤3、灭菌干燥:将步骤2得到的颗粒灭菌,并于30-60℃温度下干燥至水分含量<3%,得到中间体粉料;
步骤4、包装:将步骤3中所得的将中间体粉料进行检验,之后进行内包装、外包装,最后进行成品检验后入库。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810162283.8A CN108450962A (zh) | 2018-02-27 | 2018-02-27 | 一种用于女士保健的固体饮料及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810162283.8A CN108450962A (zh) | 2018-02-27 | 2018-02-27 | 一种用于女士保健的固体饮料及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN108450962A true CN108450962A (zh) | 2018-08-28 |
Family
ID=63216547
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810162283.8A Pending CN108450962A (zh) | 2018-02-27 | 2018-02-27 | 一种用于女士保健的固体饮料及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108450962A (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109527313A (zh) * | 2018-12-18 | 2019-03-29 | 西藏民族大学 | 一种可缓解视觉和体力疲劳的功能性饮料及其制备方法 |
CN117695371A (zh) * | 2024-02-06 | 2024-03-15 | 中科创导(山东)生物科技有限公司 | 一种用于治疗痛经的中药发酵制剂及其制备方法 |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1546015A (zh) * | 2003-12-12 | 2004-11-17 | 北京邦法姆生物医药科技有限公司 | 一种含有氨基酸钙和大豆异黄酮的组合物 |
CN101480452A (zh) * | 2008-01-07 | 2009-07-15 | 南京万舜源生物科技有限公司 | 一种用于美容养颜和妇科保健的复方及制备方法和应用 |
CN102077941A (zh) * | 2010-09-20 | 2011-06-01 | 王强 | 一种更年期女士专用的海洋特膳食品 |
CN102429218A (zh) * | 2011-10-29 | 2012-05-02 | 山西振东五和健康食品股份有限公司 | 一种适于中老年人养生保健的营养食品 |
CN104940241A (zh) * | 2015-05-29 | 2015-09-30 | 湖北圣峰药业有限公司 | 一种防治妇女更年期综合征的硒虫草复方制剂 |
CN105999233A (zh) * | 2016-05-04 | 2016-10-12 | 上海昭远生物工程有限公司 | 一种治疗女性不孕不育的药物及其制备方法 |
-
2018
- 2018-02-27 CN CN201810162283.8A patent/CN108450962A/zh active Pending
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1546015A (zh) * | 2003-12-12 | 2004-11-17 | 北京邦法姆生物医药科技有限公司 | 一种含有氨基酸钙和大豆异黄酮的组合物 |
CN101480452A (zh) * | 2008-01-07 | 2009-07-15 | 南京万舜源生物科技有限公司 | 一种用于美容养颜和妇科保健的复方及制备方法和应用 |
CN102077941A (zh) * | 2010-09-20 | 2011-06-01 | 王强 | 一种更年期女士专用的海洋特膳食品 |
CN102429218A (zh) * | 2011-10-29 | 2012-05-02 | 山西振东五和健康食品股份有限公司 | 一种适于中老年人养生保健的营养食品 |
CN104940241A (zh) * | 2015-05-29 | 2015-09-30 | 湖北圣峰药业有限公司 | 一种防治妇女更年期综合征的硒虫草复方制剂 |
CN105999233A (zh) * | 2016-05-04 | 2016-10-12 | 上海昭远生物工程有限公司 | 一种治疗女性不孕不育的药物及其制备方法 |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109527313A (zh) * | 2018-12-18 | 2019-03-29 | 西藏民族大学 | 一种可缓解视觉和体力疲劳的功能性饮料及其制备方法 |
CN117695371A (zh) * | 2024-02-06 | 2024-03-15 | 中科创导(山东)生物科技有限公司 | 一种用于治疗痛经的中药发酵制剂及其制备方法 |
CN117695371B (zh) * | 2024-02-06 | 2024-04-19 | 中科创导(山东)生物科技有限公司 | 一种用于治疗痛经的中药发酵制剂及其制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN106072573A (zh) | 一种适用于老年肌肉衰减症食用的特膳食品 | |
CN104381586A (zh) | 一种配比科学合理的大豆肽蛋白粉及其制备方法 | |
CN108703249A (zh) | 一种胶原蛋白产品及其制备方法 | |
CN106107463A (zh) | 超级藜麦抗疲劳奶茶制作工艺 | |
WO1994001006A2 (en) | Composition for use as a food or food supplement | |
GB2268871A (en) | Composition for use as a food or food supplement | |
CN105639560A (zh) | 一种用于安神助眠的生物酶解法破壁灵芝孢子粉蜂蜜及其制作工艺 | |
CN110037113A (zh) | 一种女士瘦身养颜奶粉 | |
CN101536786A (zh) | 用于控制体重的食品组合物及其制备方法 | |
CN106668507A (zh) | 一种用于治疗男性不孕不育的药物及其制备方法 | |
CN104489681A (zh) | 一种具有增强免疫力功能的组合物、保健品及其制备方法 | |
CN108450962A (zh) | 一种用于女士保健的固体饮料及其制备方法 | |
CN102318821A (zh) | 适用于准备生育的男士的特膳营养食品 | |
CN101103816B (zh) | 沙棘营养香素食品添加剂及含有该添加剂的面粉组合物 | |
CN101991110B (zh) | 野生灵芝系列食品 | |
CN104304492A (zh) | 一种牛乳钙咀嚼片及其制作工艺 | |
CN101248881B (zh) | 一种具有改善女性更年期健康作用的营养食品 | |
CN110115386A (zh) | 一种改善卵巢功能的营养组合物及其制备方法 | |
CN101999670A (zh) | 一种具有缓解疲劳、养颜再生功能的食品及其制备方法 | |
CN102499366B (zh) | 调节血脂和抗疲劳的保健食品 | |
CN108315177A (zh) | 一种药食两用藏草藏药配制酒及其制备方法 | |
CN104605352A (zh) | 用于促进人体血液循环、温补肾阳的玛卡和刺梨营养组合物,其制备方法和用途 | |
CN108095075A (zh) | 流产女性专用型临床营养配方及其制备方法 | |
CN100333652C (zh) | 一种微米糖参马桃花鹿补肾消疲奶粉制备方法 | |
CN110214955B (zh) | 一种具有滋养卵巢功能的组合物及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20180828 |